A correlated meta-analysis identified nine ERLIN1-CHUK-CWF19L1 gene variants associated with CT-diagnosed NAFLD and raised ALT levels (Feitosa et al., 2013). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.